Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 24
Filtrer
Plus de filtres











Gamme d'année
1.
Ann R Coll Surg Engl ; 99(8): e241-e243, 2017 Nov.
Article de Anglais | MEDLINE | ID: mdl-29022798

RÉSUMÉ

Simultaneous pneumoperitoneum and pneumomediastinum is a rare clinical occurrence. It has been reported in the literature as a complication of various medical and dental procedures. To our knowledge, we present the first case of a non-iatrogenic and traumatic simultaneous pneumoperitoneum and pneumomediastinum in a previously independent 91-year-old man who presented to hospital with back and chest wall pain following mechanical fall from standing. A new radiological diagnosis of diverticular disease with possible perforation was made following admission. Despite appropriate management and supportive measures, the patient died 12 days after admission from a kidney injury.


Sujet(s)
Emphysème médiastinal , Pneumopéritoine , Chutes accidentelles , Sujet âgé de 80 ans ou plus , Issue fatale , Humains , Rein/traumatismes , Mâle , Emphysème médiastinal/complications , Emphysème médiastinal/imagerie diagnostique , Emphysème médiastinal/physiopathologie , Pneumopéritoine/complications , Pneumopéritoine/imagerie diagnostique , Pneumopéritoine/physiopathologie
3.
Diabetes Metab ; 37(6): 505-11, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21636306

RÉSUMÉ

AIM: This study investigated the effects of pigment epithelium-derived factor (PEDF) on advanced glycation end-product (AGE)-induced cytotoxicity in porcine retinal pericytes and the signalling mechanism involved. METHODS: Retinal pericytes were isolated from porcine eyes and characterized by immunocytochemistry. The effect of AGEs and PEDF on cell proliferation was determined by bromodeoxyuridine (BrdU) assay. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity was analyzed by luminescence assay. Reactive oxygen species (ROS), nitric oxide (NO), superoxide dismutase (SOD) and glutathione peroxidase (GSH) were determined by biochemical assays. Induction of apoptosis was determined by caspase-3 colorimetric assay and DNA fragmentation analysis. Src activity was assessed by transient transfection analysis, and the status of Src phosphorylation at Y419 was analyzed by a competitive ELISA method. RESULTS: AGEs significantly increased intracellular ROS generation in pericytes via NADPH oxidase and induced cell death via caspase-3 enzyme activation, whereas PEDF increased cell proliferation in a dose-dependent manner. In addition, PEDF inhibited AGE-induced ROS generation by increasing levels of SOD and GSH, and also blocked the activation of caspase-3. Furthermore, PEDF induced cell survival via the Src pathway by Src phosphorylation at Y419, as evidenced by a pharmacological inhibitor and Src mutants. CONCLUSION: These results suggest that PEDF abrogates AGE-induced oxidative stress and apoptosis in retinal pericytes via the Src pathway, thereby suggesting that PEDF is an effective therapeutic agent for the treatment of loss of pericytes in early diabetic retinopathy.


Sujet(s)
Antioxydants/pharmacologie , Rétinopathie diabétique/métabolisme , Protéines de l'oeil/métabolisme , Produits terminaux de glycation avancée/effets indésirables , Facteurs de croissance nerveuse/métabolisme , Péricytes/effets des médicaments et des substances chimiques , Rétine/métabolisme , Serpines/métabolisme , Vieillissement/métabolisme , Vieillissement/anatomopathologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Rétinopathie diabétique/anatomopathologie , Test ELISA , Protéines de l'oeil/pharmacologie , Immunohistochimie , Facteurs de croissance nerveuse/pharmacologie , Péricytes/métabolisme , Péricytes/anatomopathologie , Espèces réactives de l'oxygène/métabolisme , Rétine/anatomopathologie , Serpines/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiques , Suidae
4.
Vaccine ; 27(14): 1997-2015, 2009 Mar 23.
Article de Anglais | MEDLINE | ID: mdl-19200450

RÉSUMÉ

Generating broadly neutralizing antibodies with candidate vaccines has remained an elusive goal. Consequently, vaccine candidates developed have aimed at eliciting cell-mediated immune effector activities (CMI) that could delay disease progression, and maybe also limit secondary transmission, by controlling virus replication. There is considerable discussion about what types of endpoints would constitute definable standardized clinical benefit to the individual that would result in licensure of these candidate vaccines. Identifying biomarkers that can be used as surrogates for clinical endpoints in randomized clinical trials would be useful, because it would shorten studies and reduce costs. Biological markers associated with disease progression and secondary transmission and that may be used as prognosis markers and surrogate endpoints in HIV vaccine trials have emerged from analyses of data from studies on natural history of HIV infection. Extensive literature is cited to support the use of plasma viral load as a primary endpoint for supporting licensure decisions. Overall, a significant result on viral load in a vaccine trial should be considered as a significant breakthrough for vaccines and be aggressively pursued with the caveat that such a result should rapidly be followed by well-defined studies to verify durable virological and immunological vaccine benefit, as well as ultimate clinical benefit. The review also provides perspectives on magnitude of viral load reduction, durability of viral load reduction for reduced progression of HIV disease.


Sujet(s)
Vaccins contre le SIDA/immunologie , Infections à VIH/thérapie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Charge virale , Vaccins contre le SIDA/administration et posologie , Animaux , Marqueurs biologiques/sang , Essais cliniques comme sujet , Évolution de la maladie , Humains , ARN viral/sang , Lymphocytes T cytotoxiques/immunologie
5.
Tissue Antigens ; 64(3): 251-6, 2004 Sep.
Article de Anglais | MEDLINE | ID: mdl-15304005

RÉSUMÉ

Antigen-induced cellular immunogenicity may vary between populations due to differences in human leukocyte antigen (HLA) diversity and, hence, may play a critical role in the protection afforded by vaccines. In the setting of two, phase I/II human immunodeficiency virus-1 vaccine trials of a recombinant canarypox prime, and boosting with either recombinant monomeric gp120 or oligomeric gp160, we assessed the association between specific human leukocyte antigen (HLA) class I serotypes and the presence of cytotoxic T-lymphocyte response measured by 51Cr-release assay. HLA class I serotypes A11, A24, A33, B46, and B75 were the most common, present in 10% or more of 245 individuals studied. Forty of 187 (21.4%) Thai adults who received either ALVAC-HIV with gp120 or oligomeric gp160 or ALVAC alone had a precursor cytolytic CD8 T-cell response (pCTL). HLA-B44 was positively and significantly associated with a pCTL response (odds ratio 7.6, 95% CI: 2.7-21.2), whereas B46 was negatively associated but not robust when adjusted for multiple comparisons. Responses to Env proteins accounted for the majority (nine of 11) of pCTL activity among those persons with B44. This HLA class I serotype occurred in 9.4% of participants overall (including the placebo group), less commonly than what is reported from populations of European ancestry. These results strengthen the importance of assessing HLA class I distributions in conjunction with studies of vaccines designed to elicit cellular immunity in different populations.


Sujet(s)
Infections à VIH/prévention et contrôle , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Antigènes d'histocompatibilité de classe I/immunologie , Lymphocytes T cytotoxiques/immunologie , Vaccins antiviraux/administration et posologie , Adulte , Femelle , Protéine d'enveloppe gp120 du VIH/immunologie , Protéine d'enveloppe gp160 du VIH/immunologie , Infections à VIH/immunologie , Humains , Mâle , Lymphocytes T cytotoxiques/virologie , Thaïlande , Vaccins antiviraux/immunologie
6.
J Immunol ; 166(11): 6776-83, 2001 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-11359836

RÉSUMÉ

In BALB/c mice infected with Leishmania major, early secretion of IL-4 leads to a Th2-type response and nonhealing. We explored the role of IL-4-induced down-regulation of the IL-12Rbeta2 chain in the establishment of this Th2 response. First, we showed that the draining lymph nodes of resistant C57BL/6 mice infected with L. major were enriched in CD4+/IL-12Rbeta2 chain+ cells producing IFN-gamma. Next, we demonstrated that BALB/c background mice bearing an IL-12Rbeta2-chain transgene manifested a nonhealing phenotype similar to wild-type littermates despite the persistence of their ability to undergo STAT4 activation. Finally, we found that such transgenic mice display more severe infection than wild-type littermates when treated with IL-12 7 days after infection, and under this condition, the mice display increased Leishmania Ag-induced IL-4 secretion. These studies indicate that although CD4+/IL-12Rbeta2 chain+ T cells are important components of the Th1 response, maintenance of IL-12Rbeta2 chain expression is not sufficient to change a Th2 response to a Th1 response in vivo and thus to allow BALB/c mice to heal L. major infection.


Sujet(s)
Interleukine-12/physiologie , Leishmania major/immunologie , Leishmaniose cutanée/génétique , Leishmaniose cutanée/immunologie , Souris de lignée BALB C/génétique , Souris transgéniques/immunologie , Récepteurs aux interleukines/génétique , Transgènes/immunologie , Animaux , Marqueurs génétiques/immunologie , Prédisposition génétique à une maladie , Immunité innée/génétique , Immunophénotypage , Injections péritoneales , Interleukine-12/usage thérapeutique , Interleukine-4/biosynthèse , Interleukine-4/génétique , Leishmaniose cutanée/anatomopathologie , Leishmaniose cutanée/prévention et contrôle , Noeuds lymphatiques/immunologie , Noeuds lymphatiques/parasitologie , Noeuds lymphatiques/anatomopathologie , Souris , Souris de lignée BALB C/immunologie , Souris de lignée C57BL , Récepteurs aux interleukines/biosynthèse , Récepteurs à l'interleukine-12 , Indice de gravité de la maladie , Lymphocytes auxiliaires Th1/immunologie , Lymphocytes auxiliaires Th1/métabolisme
7.
J Immunol ; 166(8): 5122-8, 2001 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-11290794

RÉSUMÉ

DNA- and protein- based vaccines against cutaneous leishmaniasis due to Leishmania major were evaluated using a challenge model that more closely reproduces the pathology and immunity associated with sand fly-transmitted infection. C57BL/6 mice were vaccinated s.c. with a mixture of plasmid DNAs encoding the Leishmania Ags LACK, LmSTI1, and TSA (AgDNA), or with autoclaved L. major promastigotes (ALM) plus rIL-12, and the mice were challenged by inoculation of 100 metacyclic promastigotes in the ear dermis. When challenged at 2 wk postvaccination, mice receiving AgDNA or ALM/rIL-12 were completely protected against the development of dermal lesions, and both groups had a 100-fold reduction in peak dermal parasite loads compared with controls. When challenged at 12 wk, mice vaccinated with ALM/rIL-12 maintained partial protection against dermal lesions and their parasite loads were no longer significantly reduced, whereas the mice vaccinated with AgDNA remained completely protected and had a 1000-fold reduction in dermal parasite loads. Mice vaccinated with AgDNA also harbored few, if any, parasites in the skin during the chronic phase, and their ability to transmit L. major to vector sand flies was completely abrogated. The durable protection in mice vaccinated with AgDNA was associated with the recruitment of both CD8(+) and CD4(+) T cells to the site of intradermal challenge and with IFN-gamma production by CD8(+) T cells in lymph nodes draining the challenge site. These data suggest that under conditions of natural challenge, DNA vaccination has the capacity to confer complete protection against cutaneous leishmaniasis and to prevent the establishment of infection reservoirs.


Sujet(s)
Calendrier vaccinal , Mémoire immunologique , Leishmania major/immunologie , Leishmaniose cutanée/immunologie , Leishmaniose cutanée/prévention et contrôle , Protéines de protozoaire/usage thérapeutique , Vaccins antiprotozoaires/usage thérapeutique , Vaccins à ADN/usage thérapeutique , Glycoprotéines de surface variables du trypanosome , Animaux , Antigènes de protozoaire/administration et posologie , Antigènes de protozoaire/génétique , Antigènes de protozoaire/immunologie , Antigènes de protozoaire/usage thérapeutique , Antigènes de surface/administration et posologie , Antigènes de surface/génétique , Antigènes de surface/immunologie , Antigènes de surface/usage thérapeutique , ADN des protozoaires/administration et posologie , ADN des protozoaires/génétique , ADN des protozoaires/immunologie , ADN des protozoaires/usage thérapeutique , Relation dose-réponse (immunologie) , Hypersensibilité retardée/immunologie , Immunité innée , Rappel de vaccin , Injections intradermiques , Vecteurs insectes/parasitologie , Interleukine-12/administration et posologie , Interleukine-12/génétique , Interleukine-12/immunologie , Interleukine-12/usage thérapeutique , Leishmania major/génétique , Leishmania major/croissance et développement , Leishmaniose cutanée/anatomopathologie , Leishmaniose cutanée/transmission , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Protéines de protozoaire/administration et posologie , Protéines de protozoaire/génétique , Protéines de protozoaire/immunologie , Vaccins antiprotozoaires/administration et posologie , Vaccins antiprotozoaires/génétique , Vaccins antiprotozoaires/immunologie , Psychodidae/parasitologie , Vaccins à ADN/administration et posologie , Vaccins à ADN/immunologie , Vaccins synthétiques/administration et posologie , Vaccins synthétiques/immunologie , Vaccins synthétiques/usage thérapeutique
8.
J Expo Anal Environ Epidemiol ; 11(6): 501-9, 2001.
Article de Anglais | MEDLINE | ID: mdl-11791166

RÉSUMÉ

The National Human Exposure Assessment Survey (NHEXAS)/Minnesota Children's Pesticide Exposure Study (MNCPES) was a population-based study designed to characterize children's exposure to residential pesticides and to evaluate the contribution of residential and children's activities to children's exposure. Families of 168 children were surveyed for residential use of pesticides and children's activities. From these homes, families of 102 children between the ages of 3 and 13 years participated in a week-long intensive exposure study. Of the 102 children, 19 children were videotaped for four consecutive hours in their normal daily activities. The survey responses indicated that the youngest children were more likely to exhibit behaviors that would foster exposure to environmental contaminants. Comparison of questionnaire responses indicated that the videotaped subsample was representative of the exposure study population. The microactivities of the videotaped children that might contribute to their exposure via ingestion or dermal routes were quantified. Hand-to-mouth and object-to-mouth activities were observed most frequently among the youngest children. The youngest children were also most likely to be barefoot both indoors and outside. Gender differences were found in mouthing behavior and the proportion of observed time spent outdoors.


Sujet(s)
Activités de la vie quotidienne , Comportement de l'enfant , Protection de l'enfance , Exposition environnementale , Pesticides/analyse , Administration par voie cutanée , Administration par voie orale , Adolescent , Enfant , Enfant d'âge préscolaire , Environnement , Femelle , Main , Enquêtes de santé , Logement , Humains , Mâle , Bouche , Facteurs sexuels , Enregistrement sur magnétoscope
9.
Mol Biol Cell ; 11(10): 3629-43, 2000 Oct.
Article de Anglais | MEDLINE | ID: mdl-11029060

RÉSUMÉ

In yeast, homologues of the synaptobrevin/VAMP family of v-SNAREs (Snc1 and Snc2) confer the docking and fusion of secretory vesicles at the cell surface. As no v-SNARE has been shown to confer endocytosis, we examined whether yeast lacking the SNC genes, or possessing a temperature-sensitive allele of SNC1 (SNC1(ala43)), are deficient in the endocytic uptake of components from the cell surface. We found that both SNC and temperature-shifted SNC1(ala43) yeast are deficient in their ability to deliver the soluble dye FM4-64 to the vacuole. Under conditions in which vesicles accumulate, FM4-64 stained primarily the cytoplasm as well as fragmented vacuoles. In addition, alpha-factor-stimulated endocytosis of the alpha-factor receptor, Ste2, was fully blocked, as evidenced using a Ste2-green fluorescent protein fusion protein as well as metabolic labeling studies. This suggests a direct role for Snc v-SNAREs in the retrieval of membrane proteins from the cell surface. Moreover, this idea is supported by genetic and physical data that demonstrate functional interactions with t-SNAREs that confer endosomal transport (e.g., Tlg1,2). Notably, Snc1(ala43) was found to be nonfunctional in cells lacking Tlg1 or Tlg2. Thus, we propose that synaptobrevin/VAMP family members are engaged in anterograde and retrograde protein sorting steps between the Golgi and the plasma membrane.


Sujet(s)
Endocytose/physiologie , Exocytose/physiologie , Protéines fongiques/physiologie , Protéines membranaires , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae/physiologie , Vacuoles/physiologie , Séquence nucléotidique , Clonage moléculaire , Endocytose/génétique , Protéines fongiques/génétique , Génotype , Facteur de conjugaison , Données de séquences moléculaires , Mutagenèse dirigée , Oligodésoxyribonucléotides , Peptides/physiologie , Protéines R-SNARE , Protéines recombinantes/métabolisme , Saccharomyces cerevisiae/génétique , Température
10.
J Expo Anal Environ Epidemiol ; 10(4): 327-40, 2000.
Article de Anglais | MEDLINE | ID: mdl-10981727

RÉSUMÉ

During the Minnesota Children's Pesticide Exposure Study (MNCPES), comparisons were made between the insecticide/herbicide loadings obtained with two household dust/insecticide or herbicide samplers: the Edwards and Lioy (EL) press sampler (used for dust collection from carpets or other surfaces) and the Lioy, Waimnan and Weisel (LWW) surface wipe sampler. The results were compared with hand rinse levels, and urine metabolite levels obtained from 102 children (ages 3-13). All measurements were made during a 1-week sampling period, and information was obtained on household pesticide use and each child's activities. Of the homes, <5% had recent spot uses of a pesticide but none had recent general applications. The analyses focused primarily on atrazine (a herbicide), and malathion, diazinon, and chlorpyrifos (insecticides). Metabolites were measured for atrazine, malathion and chlorpyrifos. The atrazine levels obtained using the EL indicate that this compound was transported into the home by an unquantified transport mechanism (e.g. tracking of soil). Two malathion hand rinse values exceeded >170 ng/cm2, suggesting that since indoor surface levels were low, these children had other sources of exposure. Atrazine, chlorpyrifos and malathion were detectable in >30% of the homes by the EL, LWW or hand rinse. Only chlorpyrifos had detectable levels in > or = 50% of the samples for all types, i.e. compound or metabolite, which is consistent with it being a common household pesticide. The median (and maximum) chlorpyrifos levels for the EL surface, EL carpet, LWW surface (two rooms), hand rinse, and urine metabolites were: 0.07 (32.6) ng/cm2; 0.07 (44.5) ng/cm2; 0.34 (3.64) ng/cm2; 0.42 (14.4) ng/cm2; 0.03 (2.14) ng/hand and 6.9 (59.0) microg/g, respectively. A strong correlation was found for chlorpyrifos between the EL surface and carpet samples. Chlorpyrifos levels detected by LWW had a different distribution and concentration range than the EL, indicating that it collected more than the surface dislodgeable insecticide. EL was directly comparable to the hand rinse or urine levels, but only the LWW had a weak correlation with hand rinse levels, suggesting that the children had other sources of chlorpyrifos exposure. Thus, mechanistic exposure studies are needed to more accurately establish exposure dose relationships in residential settings.


Sujet(s)
Exposition environnementale/analyse , Herbicides/analyse , Insecticides/analyse , Adolescent , Enfant , Comportement de l'enfant , Enfant d'âge préscolaire , Poussière , Surveillance de l'environnement/méthodes , Femelle , Désinfection des mains , Logement , Humains , Mâle , Manipulation d'échantillons/méthodes
11.
Curr Opin Immunol ; 12(4): 442-7, 2000 Aug.
Article de Anglais | MEDLINE | ID: mdl-10899026

RÉSUMÉ

Over the past few years, major advances in several areas of immunology have provided a foundation for the rational design of vaccines against diseases requiring cellular immunity. Among these advances are the cellular mechanisms by which DNA vaccines can sustain long-term humoral and cellular immunity.


Sujet(s)
Lymphocytes auxiliaires Th1/immunologie , Vaccins à ADN/immunologie , Animaux , Présentation d'antigène/immunologie , Vecteurs génétiques , Humains , Immunité cellulaire , Leishmania major/immunologie , Leishmaniose cutanée/immunologie , Leishmaniose cutanée/prévention et contrôle , Paludisme/immunologie , Paludisme/prévention et contrôle , Plasmides , Facteurs temps , Tuberculose/immunologie , Tuberculose/prévention et contrôle
12.
J Immunol ; 165(2): 915-24, 2000 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-10878366

RÉSUMÉ

Protective immunity against Leishmania major generated by DNA encoding the LACK (Leishmania homologue of receptor for activated C kinase) Ag has been shown to be more durable than vaccination with LACK protein plus IL-12. One mechanism to account for this may be the selective ability of DNA vaccination to induce CD8+ IFN-gamma-producing T cells. In this regard, we previously reported that depletion of CD8+ T cells in LACK DNA-vaccinated mice abrogated protection when infectious challenge was done 2 wk postvaccination. In this study, we extend these findings to study the mechanism by which CD8+ T cells induced by LACK DNA vaccination mediate both short- and long-term protective immunity against L. major. Mice vaccinated with LACK DNA and depleted of CD8+ T cells at the time of vaccination or infection were unable to control infection when challenge was done 2 or 12 wk postvaccination. Remarkably, it was noted that depletion of CD8+ T cells in LACK DNA-vaccinated mice was associated with a striking decrease in the frequency of LACK-specific CD4+ IFN-gamma-producing T cells both before and after infection. Moreover, data are presented to suggest a mechanism by which CD8+ T cells exert this regulatory role. Taken together, these data provide additional insight into how Th1 cells are generated and sustained in vivo and suggest a potentially novel immunoregulatory role for CD8+ T cells following DNA vaccination.


Sujet(s)
Lymphocytes T CD8+/immunologie , Lymphocytes auxiliaires Th1/immunologie , Vaccins à ADN/administration et posologie , Vaccins à ADN/immunologie , Animaux , Antigènes de protozoaire/administration et posologie , Antigènes de protozoaire/immunologie , Numération des lymphocytes CD4 , Lymphocytes T CD4+/immunologie , Lymphocytes T CD4+/métabolisme , Antigènes CD8/immunologie , Lymphocytes T CD8+/métabolisme , Division cellulaire/immunologie , Cellules cultivées , ADN des protozoaires/administration et posologie , ADN des protozoaires/immunologie , Gènes de la chaine bêta du récepteur des lymphocytes T , Sérums immuns/administration et posologie , Immunité cellulaire , Injections sous-cutanées , Interféron gamma/biosynthèse , Interleukine-12/administration et posologie , Interleukine-12/antagonistes et inhibiteurs , Interleukine-12/biosynthèse , Interleukine-12/métabolisme , Leishmania major/enzymologie , Leishmania major/génétique , Leishmania major/immunologie , Leishmaniose cutanée/immunologie , Leishmaniose cutanée/prévention et contrôle , Noeuds lymphatiques/cytologie , Noeuds lymphatiques/immunologie , Activation des lymphocytes , Souris , Souris de lignée BALB C , Souris transgéniques , Protéine kinase C/métabolisme , Protéines de protozoaire/administration et posologie , Protéines de protozoaire/génétique , Protéines de protozoaire/immunologie , Récepteurs aux interleukines/antagonistes et inhibiteurs , Récepteurs aux interleukines/biosynthèse , Récepteurs à l'interleukine-12
13.
Proc Natl Acad Sci U S A ; 97(15): 8427-32, 2000 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-10890924

RÉSUMÉ

IL-12 plays a central role in both the induction and magnitude of a primary Th1 response. A critical question in designing vaccines for diseases requiring Th1 immunity such as Mycobacterium tuberculosis and Leishmania major is the requirements to sustain memory/effector Th1 cells in vivo. This report examines the role of IL-12 and antigen in sustaining Th1 responses sufficient for protective immunity to L. major after vaccination with LACK protein (LP) plus rIL-12 and LACK DNA. It shows that, after initial vaccination with LP plus rIL-12, supplemental boosting with either LP or rIL-12 is necessary but not sufficient to fully sustain long-term Th1 immunity. Moreover, endogenous IL-12 is also shown to be required for the induction, maintenance, and effector phase of the Th1 response after LACK DNA vaccination. Finally, IL-12 is required to sustain Th1 cells and control parasite growth in susceptible and resistant strains of mice during primary and secondary infection. Taken together, these data show that IL-12 is essential to sustain a sufficient number of memory/effector Th1 cells generated in vivo to mediate long-term protection to an intracellular pathogen.


Sujet(s)
Antigènes de protozoaire/immunologie , Mémoire immunologique/immunologie , Interleukine-12/immunologie , Leishmania major/immunologie , Leishmaniose cutanée/prévention et contrôle , Protéines de protozoaire/immunologie , Vaccins antiprotozoaires/immunologie , Lymphocytes auxiliaires Th1/immunologie , Vaccins à ADN/immunologie , Animaux , Antigènes de protozoaire/génétique , Antigènes CD4/immunologie , Femelle , Immunité innée/immunologie , Interleukine-12/génétique , Leishmaniose cutanée/immunologie , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris knockout , Protéines de protozoaire/génétique , Vaccins antiprotozoaires/génétique , Facteurs temps , Vaccination , Vaccins à ADN/génétique
14.
Annu Rev Immunol ; 18: 927-74, 2000.
Article de Anglais | MEDLINE | ID: mdl-10837079

RÉSUMÉ

The development and widespread use of vaccines against infectious agents have been a great triumph of medical science. One reason for the success of currently available vaccines is that they are capable of inducing long-lived antibody responses, which are the principal agents of immune protection against most viruses and bacteria. Despite these successes, vaccination against intracellular organisms that require cell-mediated immunity, such as the agents of tuberculosis, malaria, leishmaniasis, and human immunodeficiency virus infection, are either not available or not uniformly effective. Owing to the substantial morbidity and mortality associated with these diseases worldwide, an understanding of the mechanisms involved in generating long-lived cellular immune responses has tremendous practical importance. For these reasons, a new form of vaccination, using DNA that contains the gene for the antigen of interest, is under intensive investigation, because it can engender both humoral and cellular immune responses. This review focuses on the mechanisms by which DNA vaccines elicit immune responses. In addition, a list of potential applications in a variety of preclinical models is provided.


Sujet(s)
Vaccins à ADN/immunologie , Animaux , Sécurité des produits de consommation , Vecteurs génétiques , Humains , Rats , Vaccination , Vaccins à ADN/effets indésirables
15.
J Exp Med ; 191(9): 1605-10, 2000 May 01.
Article de Anglais | MEDLINE | ID: mdl-10790434

RÉSUMÉ

We explored the role of Gi protein signaling in the regulation of interleukin (IL)-12 production and T helper cell type 1 (Th1) T cell differentiation. In initial studies, we showed that treatment of normal mice with pertussis toxin (PT), which inhibits Gi protein signaling, enhanced the capacity of splenocytes to produce IL-12 in response to both microbial and nonmicrobial stimuli. In addition, PT treatment increased the production of tumor necrosis factor (TNF)-alpha and IL-10 by stimulated cells. These findings were corroborated by the fact that untreated Gi2alpha(2/-) mice exhibited enhanced production of IL-12 and TNF-alpha by splenocytes, and of IL-12 p40 by purified spleen CD8alpha(+) lymphoid dendritic cells. Finally, we showed that while normal BALB/c mice infected with Leishmania major exhibited a nonhealing phenotype, those treated with PT when infection was initiated exhibited a healing phenotype along with an enhancement of leishmania-specific Th1 responses in draining lymph nodes. Further, healing was prevented by coadministration of anti-IL-12 and PT. These data demonstrate that endogenous Gi protein signaling has a primary role in the regulation of IL-12 production and the induction of Th1 responses in vivo.


Sujet(s)
Sous-unités alpha Gi-Go des protéines G/métabolisme , Interleukine-12/biosynthèse , Lymphocytes auxiliaires Th1/immunologie , Adénosine diphosphate ribose/métabolisme , Animaux , Antigènes CD8 , Différenciation cellulaire , Cellules dendritiques/immunologie , Sous-unités alpha Gi-Go des protéines G/génétique , Interféron gamma/biosynthèse , Interleukine-10/biosynthèse , Interleukine-4/biosynthèse , Leishmaniose cutanée/immunologie , Noeuds lymphatiques/immunologie , Souris , Souris de lignée BALB C , Souches mutantes de souris , Toxine pertussique , Maturation post-traductionnelle des protéines , Transduction du signal , Rate/cytologie , Rate/effets des médicaments et des substances chimiques , Facteur de nécrose tumorale alpha/biosynthèse , Facteurs de virulence des Bordetella/pharmacologie
17.
Nat Med ; 4(12): 1409-15, 1998 Dec.
Article de Anglais | MEDLINE | ID: mdl-9846579

RÉSUMÉ

The humoral immunity induced by many viral and bacterial vaccines mediates protection that is maintained over a long period of time. In contrast, for other intracellular infections (such as with Leishmania major or Mycobacterium tuberculosis) for which cell-mediated immunity is required for protection, the mechanisms for developing durable responses after vaccination have not been well defined. Here we demonstrate that vaccination with plasmid DNA encoding a specific leishmanial antigen is more effective than leishmanial protein plus recombinant IL-12 in eliciting long-term immunity capable of controlling L. major infection. We also show that leishmanial protein plus IL-12 DNA produces an immunity that lasts much longer than does immunity elicited by leishmanial protein plus IL-12 protein, indicating that the persistence of IL-12 may be the essential determinant in maintaining durable cell-mediated immune responses for an intracellular parasitic infection.


Sujet(s)
Antigènes de protozoaire/immunologie , Immunité cellulaire , Leishmania major/immunologie , Leishmaniose cutanée/prévention et contrôle , Protéines de protozoaire/immunologie , Vaccins antiprotozoaires/immunologie , Vaccins à ADN/immunologie , Adjuvants immunologiques/usage thérapeutique , Animaux , Interféron gamma/biosynthèse , Interleukine-12/génétique , Interleukine-12/usage thérapeutique , Leishmaniose cutanée/immunologie , Souris , Souris de lignée BALB C , Protéines recombinantes/usage thérapeutique
18.
J Immunol ; 161(9): 4563-71, 1998 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-9794383

RÉSUMÉ

CD40/CD40 ligand interactions have a central role in the induction of both humoral and cellular immunity. In this study, we examined whether a plasmid expressing CD40 ligand/trimer (CD40LT) could enhance immune responses in vivo. BALB/c mice were injected with plasmid expressing beta-galactosidase DNA with or without CD40LT DNA or IL-12 DNA, and immune responses were assessed. Mice vaccinated with beta-gal DNA plus CD40LT DNA or IL-12 DNA had a striking increase in Ag-specific production of IFN-gamma, cytolytic T cell activity, and IgG2a Ab. The mechanism by which CD40LT DNA enhanced these responses was further assessed by treating vaccinated mice with anti-IL-12 mAb or CTLA-4 Ig (CTLA4Ig). Production of IFN-gamma and CTL activity was abrogated by these treatments, suggesting that CD40LT DNA was mediating its effects on IFN-gamma and CTL activity through induction of IL-12 and enhancement of B7 expression, respectively. Physiologic relevance for the ability of CD40LT DNA to enhance immune responses by the aforementioned pathways was shown in two in vivo models. First, with regard to CTL activity, mice vaccinated with CD40LT DNA did not develop metastatic tumor following challenge with lethal dose of tumor. Moreover, in a mouse model requiring IL-12-dependent production of IFN-gamma, mice vaccinated with soluble Leishmania Ag and CD40LT DNA were able to control infection with Leishmania major. These data suggest that CD40LT DNA could be a useful vaccine adjuvant for diseases requiring cellular and/or humoral immunity.


Sujet(s)
Adjuvants immunologiques , Production d'anticorps/effets des médicaments et des substances chimiques , ADN recombiné/immunologie , Immunité cellulaire/effets des médicaments et des substances chimiques , Tumeurs du poumon/secondaire , Glycoprotéines membranaires/génétique , Vaccins synthétiques/immunologie , Animaux , Anticorps antitumoraux/biosynthèse , Antigène CD80/immunologie , Antigène CD28/immunologie , Ligand de CD40 , Tumeurs du côlon/immunologie , Tumeurs du côlon/anatomopathologie , Cytotoxicité immunologique , ADN recombiné/pharmacologie , Femelle , Gènes rapporteurs , Immunoglobuline G/biosynthèse , Interféron gamma/biosynthèse , Interleukine-12/génétique , Interleukine-12/physiologie , Leishmania major/immunologie , Leishmaniose/prévention et contrôle , Tumeurs du poumon/immunologie , Tumeurs du poumon/prévention et contrôle , Souris , Souris de lignée BALB C , Transplantation tumorale , Méthode en simple aveugle , Lymphocytes T cytotoxiques/immunologie , Lymphocytes auxiliaires Th1/immunologie , Lymphocytes auxiliaires Th1/métabolisme , Vaccination , beta-Galactosidase/génétique
20.
Environ Health Perspect ; 106(1): 9-16, 1998 Jan.
Article de Anglais | MEDLINE | ID: mdl-9417768

RÉSUMÉ

Quantitative examination of major pathways and routes of exposure to pesticides is essential for determining human risk. The current study was conducted in two apartments and examines the accumulation of the pesticide chlorpyrifos in childrens' toys after the time suggested for reentry after application. It has been established for the first time that a semivolatile pesticide will accumulate on and in toys and other sorbant surfaces in a home via a two-phase physical process that continues for at least 2 weeks postapplication. A summation of the above for a 3-6-year-old child yielded an estimated nondietary total dose of 208 microg/kg/day. Potential exposure from the inhalation pathway was negligible, while dermal and nondietary oral doses from playing with toys contributed to 39 and 61% of the total dose, respectively. If children with high frequency mouthing behavior are considered as candidates for acute exposure to chlorpyrifos residues, the estimated acute dose could be as high as 356 microg/kg/day. Routine reapplication of pesticides could lead to continued accumulation in toys and other sorbant surfaces, e.g., pillows, with large sorbant reservoirs, which can become a long-term source of exposure to a child. Estimates of a child's nondietary exposure to chlorpyrifos associated with toys and other sorbant surfaces for a period of 1 week following application appear to be of public health concern, and studies of actual childhood exposure from this pathway are warranted in the home environment. The above information should be used to determine if current procedures for postapplication reentry are sufficient and to evaluate the need for procedures to store frequently used household toys, pillows, and other sorbant objects during insecticidal application.


Sujet(s)
Chlorpyriphos/analyse , Insecticides/analyse , Résidus de pesticides/analyse , Pollution de l'air intérieur/analyse , Enfant , Enfant d'âge préscolaire , Simulation numérique , Humains , Architecture d'intérieur et mobilier , Modèles théoriques , Jeu et accessoires de jeu , Propriétés de surface
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE